The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Xeris Pharmaceuticals, Inc., a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use ...
read more
Ajinomoto Bio-Pharma Services (Aji Bio-Pharma), a leading provider of biopharmaceutical contract development and manufacturing services, announced the...
read more
Spruce Biosciences Inc. presented data from its Phase 2 clinical trial of tildacerfont in adults with classic congenital adrenal hyperplasia (CAH) at ...
read more
Moderna a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, LLC, the leading provider of high-quality ...
read more
HitGen announced that it has entered into a research collaboration agreement with Dorian Therapeutics, a private biotechnology company developing ...
read more
Pfizer announced that the first enrolled subjects have received their immunizations as part of a new study in adults ages 65 or older exploring the ...
read more
The U.S. FDA issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy sotrovimab for the treatment of mild-to-...
read more
Akorn Operating Company, a leading specialty pharmaceutical company, announced that it has entered into a definitive agreement to sell its Consumer ...
read more
Biohaven Pharmaceutical Holding Company announced that the U.S. FDA has approved NURTEC® ODT (rimegepant 75 mg) for the preventive treatment of ...
read more
The U.S. FDA and the Federal Trade Commission issued warning letters to five companies for illegally selling dietary supplements that claim to cure, ...
read more
Humanigen, a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its ...
read more
AstraZeneca’s Tagrisso (osimertinib) has been approved in the European Union (EU) for the adjuvant treatment of adult patients with early-stage (IB, ...
read more
Bristol Myers Squibb announced that the U.S. FDA approved Zeposia® (ozanimod) 0.92 mg for the treatment of adults with moderately to severely active ...
read more
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, will open its expanded production facilities ...
read more
VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine), developed ...
read more